Laboratory Centrifuges Market Size, Share and Trends 2025 to 2034

North America and Europe are important markets in the laboratory centrifuges sector, owing to the high research investments and the existing laboratory infrastructure. Emerging Asia-Pacific and Latin American economies are growing rapidly due to investments in healthcare, biotech start-ups, and research laboratories.

The main healthcare equipment manufacturers, venture capital funds, and biotechnology-oriented funds are investing in the industry, and the significant contributors are Thermo Fisher Scientific, Eppendorf, Danaher Corporation, and Beckman Coulter. Novo Holdings, SoftBank Vision Fund, and key financial and strategic partners, such as Sequoia Capital, are financing innovation in automated, IoT-enabled centrifuge technologies.

New technologies are prioritizing portable and energy-saving, and AI-based centrifuge designs to meet the needs of decentralized and point-of-care testing. The growing number of grants, incubators, and research partnerships is accelerating the commercialization and innovation processes.

Floor-Standing Centrifuge: The floor-standing centrifuge segment recorded the highest revenue in 2024, driven by rising demand for high-capacity, high-speed centrifugation in clinical and research laboratories. Such systems are desirable when large volumes of samples are to be processed, a complex workflow is needed, and the task demands higher accuracy, stability, and temperature control.

Rotor engineering, automation, and digital control interfaces have greatly improved performance and operational effectiveness. Investments in biomedical research, bioprocessing, and molecular diagnostics are still being adopted. As laboratories demands for equipment to enable high-throughput analysis and multi-sample processing have increased steadily, floor-standing centrifuges have remained the choice of high-end research institutions and large healthcare centres.

Benchtop Centrifuge: The bench-top centrifuge section will experience the highest growth rate due to increased demand for small, multi-purpose, and energy-efficient lab tools. Advanced benchtop designs have since been developed with digital touch interfaces, programmable settings, or enhanced speed control, and can therefore be used in routine testing and specialized research.

The improvements in the usability of small- and medium-sized labs include innovations such as automated imbalance detection, reduced noise, and improved rotor safety. Its space-saving nature and portability are ideal in clinical diagnosis, biotechnology research, pharmaceutical development, and academic institutions.

Clinical Centrifuge: The clinical centrifuge segment is the market leader in 2024, as it is a significant component of diagnostic procedures in hospitals, pathology laboratories, and clinical research centers. These centrifuges are crucial to the handling of samples (blood and biological), which assist in the diagnosis of a disease, hematology, and biomarker studies. The application grew due to the increasing prevalence of chronic and infectious diseases and the need for high-throughput diagnostics.

The development of molecular testing, point-of-care diagnostics, and precision medicine introduced the need for high-speed, automated systems capable of processing small-volume samples with increased accuracy. The increase in healthcare expenditure and the trend toward modernizing laboratory facilities enhanced market leadership.

Preclinical Centrifuges: The preclinical centrifuges segment will experience high growth driven by rising clinical research projects and expanding sales pipelines in pharmaceutical and biotech development. The increased in investment in drug discovery, biologics, gene therapy, and cell-based research, where specialized sample separation and purification are required, is driving growth. Preclinical centrifuges enable processing of biological materials needed for therapeutic validation, safety testing, and mechanism-of-action studies.

They are also adopted because of the need for advanced, high-speed, controlled-temperature platforms that are reproducible across complex workflows. Ongoing technological innovation and partnerships between research institutions and equipment manufacturers also contribute to the markets continued growth.

General Purpose Centrifuges: A general-purpose centrifuge is one of the most widely used segments, as it is used across a range of applications in the clinical, academic, industrial, and biotechnology markets. Their flexibility and ability to handle diverse samples, including blood components and even cell suspension samples, drive their popularity in day-to-day laboratory operations. These systems facilitate sedimentation, sample clarification, and sample preparation for downstream analysis.

It is also increasing with more research partnerships, expanding lab facilities, and the need to use cheaper technology, thereby driving more adoption. Manufacturers are improving product features to include digital interfaces, variable-speed control, and enhanced rotor safety to accommodate multi-disciplinary laboratory requirements.

Microbiology: The microbiology department recorded the highest revenue in 2024 because it is relevant to the identification and testing of microorganisms in clinical diagnosis, pharmaceutical research, environmental analysis, and food safety analysis. Laboratory centrifuges facilitate the isolation, concentration, and purification of microbial cells, as well as the appropriate identification and quantification in both culture-based and molecular evaluations.

The pressure on demand for high-performance centrifuges has also been increased by growing concerns about antimicrobial resistance, the emergence of new infectious pathogens, and the quality control requirements of biomanufacturing. The segment is expanding because labs are focusing on faster, automated, and more precise microbiological tests to support surveillance of public health and research efforts.

Diagnostics: The diagnostics segment is projected to experience the highest growth rate in the market between 2025 and 2034, as demand for early detection increases, and biomarker testing utilization increases. Laboratory centrifuges will be necessary to separate plasma, serum, and cellular components, enabling proper analysis of clinical samples in hematology, virology, oncology, and immunoassays.

The increase is also facilitated by the development of point-of-care testing, regular screening activities, and upgrades to diagnostic laboratories. Ongoing improvements in automated systems, standard workflows, and integration with digital laboratory systems increase test accuracy and centrifuge throughput, which are essential in clinical diagnostics.

Genomics: The genomics segment is also showing notable growth in the market for laboratory centrifuges, as research institutions and biotechnology companies invest more in DNA, RNA, and protein-based research. Nucleic acids and cell fractionation. Laboratory centrifuges are used in workflows for nucleic acid extraction, cell fractionation, and sample purification, which are needed for sequencing, cell gene expression, and genome editing.

The growing trend toward personalized medicine, targeted therapies, and advanced molecular research is driving the need for high-speed, temperature-controlled centrifuge systems. Their use is further enhanced by greater compatibility with microtubes, culture plates, and next-generation sequencing sample formats. This will lead to more rapid growth of the segment as more organizations in the genomic research field and equipment suppliers work together.

The laboratory centrifuges market in Asia Pacific is also growing rapidly due to expanding healthcare infrastructure, increased pharmaceutical research, and greater government focus on biotechnology and clinical diagnostics. The major manufacturers are also expanding through regionalization, localization, and strategic investments. The use of elaborate centrifuge systems is being boosted by rising demand for molecular tests, infectious disease screening, and individualized medicine. Academic research, clinical trials, and bioprocessing also increase the markets momentum. With the modernization of labs and the building of capacity as the main concerns among emerging economies, the region is a prime target for future market growth.

China Laboratory Centrifuges Market Trends

Chinas laboratory centrifuge market is growing, driven by swift improvements in healthcare infrastructure, rising investments in biotechnology and pharmaceutical research and development, and robust government support for life sciences innovation. The nation is becoming a biopharmaceutical manufacturing center, with genomic studies and clinical trials driving the need for a high-speed, automated, temperature-controlled centrifuge.

Local manufacturers are also becoming more competitive because they are producing low-cost equipment with improved safety, digital interfaces, and the ability to integrate with other state-of-the-art sample workflows. International players are also increasing through joint ventures, research collaborations, and localized production. The increasing attention to disease monitoring, precision medicine, and laboratory innovation continues to drive market growth.

The European laboratory centrifuges market is witnessing sustainable growth driven by increased investment in life sciences, growth in biotechnology research, and interest in early disease diagnostics and individualized treatment. The area is enjoying a robust academic and clinical research base, well-established regulatory guidelines, and increased use of automated laboratory devices.

The performance and efficiency are further enhanced by advances in centrifuge design, including high-throughput capabilities, rotor safety, and built-in data monitoring systems. The growing demand in pharmaceutical manufacturing, genomics, environmental testing, and clinical diagnostics, with financial support for scientific innovation from public and private funds.

UK Laboratory Centrifuges Market Trends

The UK market for laboratory centrifuges is being driven by advances in diagnostic accuracy, biomedical research, and increased investment in genomic medicine and healthcare innovation. The trend towards using more advanced centrifuge technologies in biotech companies, universities, and research institutions is being observed in these facilities, making molecular biology, cell research, and biopharmaceutical production more accessible. Adoption is also enhanced by strong government programs in clinical innovation and healthcare modernization. The market expansion is still being influenced by increasing demand for advanced laboratory infrastructure, especially in the public healthcare laboratories and research clusters.

Beckman Coulter is a major provider of automated centrifuges, clinical analyzers, and lab automation systems. Their centrifugation technologies support high-throughput clinical labs, bioprocessing, and life science research.

One of the largest global suppliers of laboratory equipment, offering a full range of centrifuges including micro, refrigerated, and high-speed models. Thermo Fisher integrates digital connectivity, advanced rotor technologies, and robust safety systems.

A German manufacturer specializing in compact and mid-sized centrifuges for hospitals, research labs, and industrial testing. Hermle systems are valued for reliability, simplified user interfaces, and long-term performance.

A Japanese manufacturer providing a wide array of laboratory centrifuges for clinical diagnostics, biological research, and material testing. Kubota offers efficient, quiet, and user-friendly designs tailored to routine lab workflows.

Known for its bioprocessing and laboratory technologies, Sartorius offers centrifuges used in cell harvesting, protein purification, and molecular biology. The company focuses on precision, reproducibility, and integration with broader lab systems.

A specialized German producer of high-quality centrifuges, including refrigerated, high-speed, and ultracentrifuge models. Sigma emphasizes performance, energy efficiency, and custom rotor compatibility.

Provides sample preparation and molecular biology kits complemented by centrifuge systems integrated into nucleic acid extraction workflows. QIAGEN supports genomics, diagnostics, and biomarker discovery.

Offers centrifugation solutions integrated within broader analytical and sample-preparation workflows. Agilent focuses on precision instrumentation for chromatography, mass spectrometry, and laboratory automation.

Supplies clinical and diagnostic centrifuges used in blood processing, sample separation, and hospital labs. BDs systems support quality-controlled workflows for immunology and hematology applications.

A global healthcare distributor providing laboratory centrifuges and related consumables to clinical and point-of-care facilities. Cardinal focuses on accessibility, supply chain reliability, and standardized equipment solutions.

Offers laboratory instruments and centrifugation systems utilized in diagnostic and research environments. The company emphasizes affordability and dependable performance for small and mid-sized labs.

A major laboratory equipment manufacturer recognized for microcentrifuges, refrigerated centrifuges, and sample-handling technologies. Eppendorf systems are widely used in molecular biology, biochemistry, and cell research.